You can buy or sell Gossamer Bio and other stocks, options, ETFs, and crypto commission-free!
Gossamer Bio, Inc. engages in discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. Its primary product candidate is GB001, which is intended for the treatment of moderate-to-severe eosinophilic asthma and other allergic conditions. Read More The company was founded by Faheem Hasnain and Sheila Gujrathi in 2015 and is headquartered in San Diego, CA.
San Diego, California
52 Week High
52 Week Low
Expected Nov 7, After Hours